Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 98 of 124)
- Relevance
  Sort by

Nasopharynx Cancer Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
183 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Targeted Cancer Therapy Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

 Report
October 2023
188 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Human Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
February 2024
141 Pages
Global

€4898EUR$4,995USD£4,081GBP

Pituitary Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
175 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Metastatic Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
190 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Malignant Mesothelioma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
190 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

North America Head and Neck Cancer Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
138 Pages
North America

From

€3922EUR$4,000USD£3,268GBP

Lichen Sclerosus Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
92 Pages
Global

From

€3500EUR$3,823USD£3,018GBP

Peripheral Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
January 2024
150 Pages
Global

From

€4756EUR$4,850USD£3,963GBP

Bispecific Antibody Market By Product (Blinatumomab, Emicizumab, Others), By Applications (Cancer, Hemophilia, Others), By End User (Hospitals, Cancer Center, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
July 2023
382 Pages
Global

From

€3501EUR$3,570USD£2,917GBP

NK Cell therapies - Pipeline Insight, 2024

 Clinical Trials
January 2024
120 Pages
Global

From

€2059EUR$2,100USD£1,716GBP

€2942EUR$3,000USD£2,451GBP

Japan CAR-T Cell Therapy Market, Competition, Forecast & Opportunities, 2028

 Report
October 2023
81 Pages
Japan

From

€3432EUR$3,500USD£2,860GBP

TNF Alpha Inhibitors Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Checkpoint Inhibitors Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Drugs for Immunotherapy Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Gestational Trophoblastic Disease Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Oral Cancer Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Germ Cell Tumor Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Gastrointestinal Stromal Tumor Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Laryngeal Cancer Therapeutics Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

2,461 Results (Page 98 of 124)
- 1
- 96
- 97
- 98
- 99
- 100

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.